Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2010
05/26/2010CN1916050B Injectable temperature sensitive hydrogel of poly (lactide - glycolide - p-dioxane ketone) - polyethyleneglycol block copolymer
05/26/2010CN1913878B Transdermal delivery of hormones without the need of penetration enhancers
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1870982B Composition containing reduced coenzyme q
05/26/2010CN1845938B Polypeptides
05/26/2010CN1838967B Stabilized immunogenic HBc chimer particles
05/26/2010CN1832751B Periodontal disease therapeutic and/or preventive composition
05/26/2010CN1829735B Imaging agents
05/26/2010CN1814301B Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
05/26/2010CN1794976B Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals
05/26/2010CN1781545B Method for extracting herbal medicine
05/26/2010CN1758899B Dosage form having a saccharide matrix
05/26/2010CN1750809B Fast dissolving orally consumable films containing pharmaceutically active agents
05/26/2010CN1744913B Use of the cathelicidin LL-37 and derivatives thereof for wound healing
05/26/2010CN1744827B Novel compositions comprising carotenoids
05/26/2010CN1736384B Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation
05/26/2010CN1733296B Stable liquid interferon formulations
05/26/2010CN1723219B Protein complex using immunoglobulin fragment and method for the preparation thereof
05/26/2010CN1723206B High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
05/26/2010CN1684709B Medicine carrier for local application
05/26/2010CN1681386B Compositions and products containing s-equol, and methods for their making
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1665933B Immunoconjugates for the treatment of tumours
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1655772B Plaster containing fentanyl
05/26/2010CN1655769B Polysaccharide capsules and methods of preparation
05/26/2010CN1655762B Ibuprofen suspension
05/26/2010CN1646171B Novel biomaterials, their preparation and use
05/26/2010CN1642538B Use of adapalene for the treatment of dermatological disorders
05/26/2010CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/26/2010CN1635872B Proliposomal drug delivery system
05/26/2010CN1596313B Humanized collagen antibodies and related methods
05/26/2010CN1589155B Animal feeds including actives and methods of using the same
05/26/2010CN1512884B 阿立哌唑口服溶液 Aripiprazole Oral Solution
05/26/2010CN1496270B Pharmaceutical composition based on macrolides for topical application in ophthalmology
05/26/2010CN1489455B Delayed release pharmaceutical formulations
05/26/2010CN1422949B Method for producing and converting manioc protoplasm
05/26/2010CN101712798A Compound consisting of metal nano-particles and cell membrane biomimetic-modification arborized polyamide-amine and preparation method
05/26/2010CN101712722A Glp-1 fusion proteins
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/26/2010CN101711877A Chitosan vehicle and method for making same
05/26/2010CN101711876A Polyethylene glycol modified recombinant human granulocyte colony-stimulating factor and preparation method thereof
05/26/2010CN101711875A Soft capsule shell composition, soft capsule prepared from same and method for preparing soft capsule shell composition and soft capsule
05/26/2010CN101711874A Application of cell penetrating peptide Tat-mediated growth factor in transdermal transfer
05/26/2010CN101711873A Method for preparing amphiphilic chitosan nanometer medicament carrier
05/26/2010CN101711872A Nano gold spherical shell material, preparation method and application in preparing medicaments for treating tumors
05/26/2010CN101711871A Silver nano-chain meshed material, preparation method thereof and application in preparing medicine for curing tumor
05/26/2010CN101711870A Carrier of composite targeting medicament delivery system and preparation method thereof
05/26/2010CN101711863A Vaccine eye drops used for treating and preventing glaucoma and preparation method
05/26/2010CN101711857A Film coating agent for treating whitevein and preparation method thereof
05/26/2010CN101711799A Externally-applied powder used for midwifery of piglets
05/26/2010CN101711796A Application of scullcapflavone in preparing medicament for treating enterovirus infection
05/26/2010CN101711772A Medicine for treating gastropathy and preparation method thereof
05/26/2010CN101711762A Medicine composition for treating hypertension
05/26/2010CN101711761A Compositions for prevention and treatment of cold and influenza-like symptoms and use methods thereof.
05/26/2010CN101711755A Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
05/26/2010CN101711753A Preparation method of lansoprazole solid preparation
05/26/2010CN101711751A Febuxostat dispersing tablet preparation and preparation method thereof
05/26/2010CN101711748A Method for preparing cefaclor dispersible tablets by dry method direct tablet compressing and cefaclor dispersible tablets prepared by same
05/26/2010CN101711745A Intraocular nano particle freeze-dried powders and preparation method thereof
05/26/2010CN101711743A Febuxostat dry suspension and preparation method thereof
05/26/2010CN101711742A Cefaclor submicro-emulsion solid preparation and novel application thereof
05/26/2010CN101711741A Cefixime submicro-emulsion solid preparation and novel application thereof
05/26/2010CN101711737A Agents for intravitreal administration to treat or prevent disorders of the eye
05/26/2010CN101711736A Method for preparing medicine-carrying microvesicle
05/26/2010CN101711735A Slow-release medicament release system as well as preparation method and application thereof
05/26/2010CN101314042B Water-soluble 4'-nor-epipodophyllotoxin derivant and preparation method thereof
05/26/2010CN101283984B Core particle object coated by fungicide and polymer with high biological usage
05/26/2010CN101161241B Technique of preparing amlodipine besylate tablets
05/26/2010CN101152184B Diclazuril effervescence patch for birds
05/26/2010CN101152158B Method of producing double-layer core permeation pump patch of medicament
05/26/2010CN101066458B Application of cell nucleus targeting administration system capable of reversing tumor cell resistance
05/26/2010CN101066258B Inclusion compound of higher fatty alcohol and its preparation
05/26/2010CN101049325B Method for preparing processed product of Chinese ephedra of Chinese traditional medicine
05/26/2010CN101040847B Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same
05/26/2010CN101032531B Hyperfine Chinese traditional medicine pieces taken with or without water and the preparing method
05/26/2010CN101032484B Capsule type tiotropium bromide inhalation powder
05/26/2010CN101028281B Nano-gel pectin bismuth and its granules medicine
05/26/2010CN101019836B Nanometer cytochrome liposome medicine and its preparation
05/25/2010US7723570 Transgenic soybean or soy protein product and a mutant cholera toxin adjuvant; the soybean is transformed with an exogenous nucleotide sequence that expresses Staphylococcus enterotoxin B; the mutant cholera toxin adjuvant is coexpressed with the SEB or is added separately
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723474 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
05/25/2010US7723432 polymer conjugate is formed by reacting a water soluble polymer having terminal hydroxy group such as polyoxyethylene glycol with di(1-benzotriazolyl)carbonate (di-BTC) to form a 1-benzotriazolylcarbonate ester, then reacting with a bioactive agent; pegylation of proteins, peptides; no phosgene used
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723305 Abuse-resistant amphetamine prodrugs
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium
05/25/2010US7723089 PEG-urate oxidase conjugates and use thereof
05/25/2010US7723056 Particles
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7722906 Topical formulations containing octadecadienoic and/or octadecenoic acid; infections, skin conditions, fissures, hemorrhoids, inflammation, pain, allergic reactions, septic wounds
05/25/2010US7722896 Biocompatible polyarylates of diphenol compounds and poly(alkylene oxide) dicarboxylic acids, articles formed therefrom and therapeutic uses are disclosed.
05/25/2010US7722891 Multiple emulsions
05/25/2010US7722890 Immunogens based on beta -D-mannopyranose; cell wall oligosaccharides similar to beta-mannans
05/25/2010US7722859 Polymer comprising water-soluble units and LCST units, and aqueous composition comprising it
05/25/2010US7722857 one or more kinds of immunostimulating substances carried separately by two or more kinds of microparticle immunostimulating substance carriers and comprising a combination of inorganic substance such as microparticle calcium phosphate and precipitates of soluble protein and mucopolysaccharide; antitumor
05/25/2010US7722855 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell
05/25/2010US7722671 Medical devices with associated growth factors
05/25/2010CA2577589C Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation
05/25/2010CA2498062C Conjugates of insulin-like growth factor binding protein-4 and poly(ethylene glycol)
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 1712